Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032
2.3 Market Size & Forecast, By Segmentation, 2021–2032
2.3.1 Market Size By Product
2.3.2 Market Size By Application
2.3.3 Market Size By Technology
2.3.4 Market Size By End-Use
2.4 Market Share & BPS Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Reimbursement & Coverage Trends
4.1.1 Payer Coverage Analysis By Country
4.1.2 Cost-Efficiency and HTA (Health Technology Assessment) Trends
4.2 Investment & Funding Insights
4.2.1 Venture Capital and Funding Trends (2020–2024)
4.2.2 Public-Private Partnership Initiatives
4.3 Adoption of AI and Bioinformatics Tools
4.3.1 Integration of AI in Data Interpretation
4.3.2 Trends in Cloud Genomics and Data Sharing Platforms
5. Genomics In Cancer Care Market Segmental Analysis & Forecast, By Product, 2021 – 2032, Value (USD Billion)
5.1 Introduction
5.2 Instruments
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2021 – 2032
5.3 Consumables
5.3.1 Key Trends
5.3.2 Market Size & Forecast, 2021 – 2032
5.4 Services
5.4.1 Key Trends
5.4.2 Market Size & Forecast, 2021 – 2032
6. Genomics In Cancer Care Market Segmental Analysis & Forecast, By Application, 2021 – 2032, Value (USD Billion)
6.1 Introduction
6.2 Diagnostics
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2021 – 2032
6.3 Personalized Medicine
6.3.1 Key Trends
6.3.2 Market Size & Forecast, 2021 – 2032
6.4 Drug Discovery & Development
6.4.1 Key Trends
6.4.2 Market Size & Forecast, 2021 – 2032
6.5 Research
6.5.1 Key Trends
6.5.2 Market Size & Forecast, 2021 – 2032
7. Genomics In Cancer Care Market Segmental Analysis & Forecast, By Technology, 2021 – 2032, Value (USD Billion)
7.1 Introduction
7.2 Genome Sequencing
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2021 – 2032
7.3 PCR
7.3.1 Key Trends
7.3.2 Market Size & Forecast, 2021 – 2032
7.4 Microarrays
7.4.1 Key Trends
7.4.2 Market Size & Forecast, 2021 – 2032
7.5 Nucleic Acid Extraction and Purification
7.5.1 Key Trends
7.5.2 Market Size & Forecast, 2021 – 2032
7.6 Sanger Sequencing
7.6.1 Key Trends
7.6.2 Market Size & Forecast, 2021 – 2032
7.7 Digital Droplet PCR (ddPCR)
7.7.1 Key Trends
7.7.2 Market Size & Forecast, 2021 – 2032
7.8 RNA sequencing (transcriptomics)
7.8.1 Key Trends
7.8.2 Market Size & Forecast, 2021 – 2032
7.9 Epigenomics tools (e.g., methylation arrays, chromatin immunoprecipitation sequencing)
7.9.1 Key Trends
7.9.2 Market Size & Forecast, 2021 – 2032
8. Genomics In Cancer Care Market Segmental Analysis & Forecast, By End-Use, 2021 – 2032, Value (USD Billion)
8.1 Introduction
8.2 Hospitals & Clinics
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2021 – 2032
8.3 Academic & Research Institutes
8.3.1 Key Trends
8.3.2 Market Size & Forecast, 2021 – 2032
8.4 Biotechnology & Pharmaceutical Companies
8.4.1 Key Trends
8.4.2 Market Size & Forecast, 2021 – 2032
8.5 Diagnostic Laboratories
8.5.1 Key Trends
8.5.2 Market Size & Forecast, 2021 – 2032
9. Genomics In Cancer Care Market Segmental Analysis & Forecast By Region, 2021 – 2025, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.2.3 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.2.4 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.2.5 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.2.6 Genomics In Cancer Care Market Size & Forecast, By Country, 2021 – 2032
9.2.6.1 USA
9.2.6.1.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.2.6.1.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.2.6.1.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.2.6.1.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.2.6.2 Canada
9.2.6.2.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.2.6.2.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.2.6.2.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.2.6.2.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.3 Europe
9.3.1 Key Trends
9.3.2 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.3.3 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.3.4 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.3.5 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.3.6 Genomics In Cancer Care Market Size & Forecast, By Country, 2021 – 2032
9.3.6.1 Germany
9.3.6.1.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.3.6.1.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.3.6.1.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.1.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.3.6.2 UK
9.3.6.2.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.3.6.2.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.3.6.2.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.2.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.3.6.3 France
9.3.6.3.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.3.6.3.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.3.6.3.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.3.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.3.6.4 Italy
9.3.6.4.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.3.6.4.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.3.6.4.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.4.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.3.6.5 Spain
9.3.6.5.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.3.6.5.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.3.6.5.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.5.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.3.6.6 Russia
9.3.6.6.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.3.6.6.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.3.6.6.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.6.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.3.6.7 Poland
9.3.6.7.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.3.6.7.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.3.6.7.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.7.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.3.6.8 Rest of Europe
9.3.6.8.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.3.6.8.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.3.6.8.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.3.6.8.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.4.3 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.4.4 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.4.5 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.4.6 Genomics In Cancer Care Market Size & Forecast, By Country, 2021 – 2032
9.4.6.1 China
9.4.6.1.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.4.6.1.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.4.6.1.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.1.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.4.6.2 India
9.4.6.2.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.4.6.2.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.4.6.2.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.2.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.4.6.3 Japan
9.4.6.3.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.4.6.3.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.4.6.3.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.3.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.4.6.4 South Korea
9.4.6.4.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.4.6.4.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.4.6.4.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.4.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.4.6.5 Australia
9.4.6.5.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.4.6.5.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.4.6.5.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.5.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.4.6.6 ASEAN Countries
9.4.6.6.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.4.6.6.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.4.6.6.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.6.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.4.6.7 Rest of Asia-Pacific
9.4.6.7.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.4.6.7.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.4.6.7.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.4.6.7.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.5 Latin America
9.5.1 Key Trends
9.5.2 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.5.3 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.5.4 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.5.5 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.5.6 Genomics In Cancer Care Market Size & Forecast, By Country, 2021 – 2032
9.5.6.1 Brazil
9.5.6.1.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.5.6.1.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.5.6.1.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.5.6.1.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.5.6.2 Argentina
9.5.6.2.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.5.6.2.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.5.6.2.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.5.6.2.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.5.6.3 Mexico
9.5.6.3.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.5.6.3.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.5.6.3.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.5.6.3.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.5.6.4 Colombia
9.5.6.4.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.5.6.4.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.5.6.4.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.5.6.4.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.5.6.5 Rest of Latin America
9.5.6.5.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.5.6.5.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.5.6.5.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.5.6.5.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.6.3 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.6.4 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.6.5 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.6.6 Genomics In Cancer Care Market Size & Forecast, By Country, 2021 – 2032
9.6.6.1 UAE
9.6.6.1.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.6.6.1.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.6.6.1.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.6.6.1.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.6.6.2 Saudi Arabia
9.6.6.2.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.6.6.2.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.6.6.2.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.6.6.2.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.6.6.3 Qatar
9.6.6.3.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.6.6.3.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.6.6.3.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.6.6.3.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.6.6.4 Egypt
9.6.6.4.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.6.6.4.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.6.6.4.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.6.6.4.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.6.6.5 South Africa
9.6.6.5.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.6.6.5.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.6.6.5.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.6.6.5.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
9.6.6.6 Rest of Middle East & Africa
9.6.6.6.1 Genomics In Cancer Care Market Size & Forecast, By Product, 2021 – 2032
9.6.6.6.2 Genomics In Cancer Care Market Size & Forecast, By Application, 2021 – 2032
9.6.6.6.3 Genomics In Cancer Care Market Size & Forecast, By Technology, 2021 – 2032
9.6.6.6.4 Genomics In Cancer Care Market Size & Forecast, By End-Use, 2021 – 2032
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2024
10.2.2 Year-Wise Strategies & Development, 2021 – 2025
10.2.3 Number of Strategies Adopted by Key Players, 2024
10.3 Market Share Analysis, 2024
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6 Key Company Profiles
10.6.1 Agilent Technologies
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Roche Diagnostics
10.6.2.1 Company Overview & Snapshot
10.6.2.2 Product/Service Portfolio
10.6.2.3 Key Company Financials
10.6.2.4 SWOT Analysis
10.6.3 Beckman Coulter
10.6.3.1 Company Overview & Snapshot
10.6.3.2 Product/Service Portfolio
10.6.3.3 Key Company Financials
10.6.3.4 SWOT Analysis
10.6.4 Illumina Inc.
10.6.4.1 Company Overview & Snapshot
10.6.4.2 Product/Service Portfolio
10.6.4.3 Key Company Financials
10.6.4.4 SWOT Analysis
10.6.5 Abbott Laboratories
10.6.5.1 Company Overview & Snapshot
10.6.5.2 Product/Service Portfolio
10.6.5.3 Key Company Financials
10.6.5.4 SWOT Analysis
10.6.6 Cancer Genetics Inc.
10.6.6.1 Company Overview & Snapshot
10.6.6.2 Product/Service Portfolio
10.6.6.3 Key Company Financials
10.6.6.4 SWOT Analysis
10.6.7 Bio-Rad Laboratories
10.6.7.1 Company Overview & Snapshot
10.6.7.2 Product/Service Portfolio
10.6.7.3 Key Company Financials
10.6.7.4 SWOT Analysis
10.6.8 Pacific Biosciences
10.6.8.1 Company Overview & Snapshot
10.6.8.2 Product/Service Portfolio
10.6.8.3 Key Company Financials
10.6.8.4 SWOT Analysis
10.6.9 GE Healthcare
10.6.9.1 Company Overview & Snapshot
10.6.9.2 Product/Service Portfolio
10.6.9.3 Key Company Financials
10.6.9.4 SWOT Analysis
10.6.10 Quest Diagnostics
10.6.10.1 Company Overview & Snapshot
10.6.10.2 Product/Service Portfolio
10.6.10.3 Key Company Financials
10.6.10.4 SWOT Analysis
10.6.11 PerkinElmer Inc.
10.6.11.1 Company Overview & Snapshot
10.6.11.2 Product/Service Portfolio
10.6.11.3 Key Company Financials
10.6.11.4 SWOT Analysis
10.6.12 Luminex Corporation
10.6.12.1 Company Overview & Snapshot
10.6.12.2 Product/Service Portfolio
10.6.12.3 Key Company Financials
10.6.12.4 SWOT Analysis
10.6.13 Thermo Fisher Scientific
10.6.13.1 Company Overview & Snapshot
10.6.13.2 Product/Service Portfolio
10.6.13.3 Key Company Financials
10.6.13.4 SWOT Analysis
10.6.14 Guardant Health Inc
10.6.14.1 Company Overview & Snapshot
10.6.14.2 Product/Service Portfolio
10.6.14.3 Key Company Financials
10.6.14.4 SWOT Analysis
10.6.15 Sysmex Corporation
10.6.15.1 Company Overview & Snapshot
10.6.15.2 Product/Service Portfolio
10.6.15.3 Key Company Financials
10.6.15.4 SWOT Analysis
10.6.16 Personalis Inc.
10.6.16.1 Company Overview & Snapshot
10.6.16.2 Product/Service Portfolio
10.6.16.3 Key Company Financials
10.6.16.4 SWOT Analysis
10.6.17 Natera Inc.
10.6.17.1 Company Overview & Snapshot
10.6.17.2 Product/Service Portfolio
10.6.17.3 Key Company Financials
10.6.17.4 SWOT Analysis
10.6.18 DNAnexus
10.6.18.1 Company Overview & Snapshot
10.6.18.2 Product/Service Portfolio
10.6.18.3 Key Company Financials
10.6.18.4 SWOT Analysis
10.6.19 QIAGEN
10.6.19.1 Company Overview & Snapshot
10.6.19.2 Product/Service Portfolio
10.6.19.3 Key Company Financials
10.6.19.4 SWOT Analysis
10.6.20 Exact Sciences Corporation
10.6.20.1 Company Overview & Snapshot
10.6.20.2 Product/Service Portfolio
10.6.20.3 Key Company Financials
10.6.20.4 SWOT Analysis
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions On Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
